2004
The Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study Approaches to control rate in atrial fibrillation
Olshansky B, Rosenfeld LE, Warner AL, Solomon AJ, O'Neill G, Sharma A, Platia E, Feld GK, Akiyama T, Brodsky MA, Greene HL, Investigators A. The Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study Approaches to control rate in atrial fibrillation. Journal Of The American College Of Cardiology 2004, 43: 1201-1208. PMID: 15063430, DOI: 10.1016/j.jacc.2003.11.032.Peer-Reviewed Original ResearchMeSH KeywordsAdrenergic beta-AntagonistsAgedAnti-Arrhythmia AgentsAtrial FibrillationCalcium Channel BlockersCatheter AblationDigoxinDrug Therapy, CombinationElectrocardiography, AmbulatoryFemaleFollow-Up StudiesHeart RateHumansMaleMiddle AgedMultivariate AnalysisPacemaker, ArtificialStroke VolumeTreatment OutcomeConceptsCalcium channel blockersAtrial Fibrillation FollowAtrial fibrillationChannel blockersAFFIRM studyDrug classesFirst drugAdequate rate controlFirst drug classFrequent medication changesRhythm Management (AFFIRM) studyMajority of patientsBeta-adrenergic blockersRate control drugsElectrocardiographic resultsMedication changesWalk testInitial treatmentClinical variablesEfficacy criteriaDrug combinationsHeart rateEffective drugsPatientsMultivariate analysis
1998
Amiodarone Induced Pulmonary Fibrosis in Infancy
BOWERS P, FIELDS J, SCHWARTZ D, ROSENFELD L, NEHGME R. Amiodarone Induced Pulmonary Fibrosis in Infancy. Pacing And Clinical Electrophysiology 1998, 21: 1665-1667. PMID: 9725167, DOI: 10.1111/j.1540-8159.1998.tb00257.x.Peer-Reviewed Original ResearchConceptsInduced Pulmonary FibrosisPulmonary fibrosisDiffuse interstitial infiltratesPediatric age groupAtrioventricular reentrant tachycardiaPediatric arrhythmiasInterstitial infiltratesWolff-ParkinsonReentrant tachycardiaWhite syndromeChest radiographsFibrosisAge groupsAmiodaroneInfantsMonthsFirst reportInfiltratesComplicationsTachycardiaAntiarrhythmiaArrhythmiasSyndromeRadiographs
1996
Initial Single‐Center Experience with an Advanced Third‐Generation Investigational Defibrillator
LAMPERT R, ROSENFELD L, McPHERSON C, LEWIS R, VANZETTA A, BATSFORD W. Initial Single‐Center Experience with an Advanced Third‐Generation Investigational Defibrillator. Pacing And Clinical Electrophysiology 1996, 19: 2072-2082. PMID: 8994946, DOI: 10.1111/j.1540-8159.1996.tb03281.x.Peer-Reviewed Original ResearchMeSH KeywordsAgedDefibrillators, ImplantableElectrocardiographyEquipment DesignFemaleFollow-Up StudiesHumansMaleTachycardiaConceptsImplantable cardioverter defibrillatorDefibrillation thresholdInitial single-center experienceYale-New Haven HospitalShocking electrodesSingle-center experienceLow-energy biphasic shocksBiphasic defibrillation thresholdLower defibrillation thresholdInappropriate therapyVentricular arrhythmiasVT zoneNonthoracotomy implantationCardioverter defibrillatorEffective treatmentVF zoneAV dissociationTransvenous systemsPatientsAvailable electrogramsNoninvasive electrophysiologyRR intervalsEPS resultsTherapyBiphasic shocks
1992
Strategies in the Surgical Treatment of Malignant Ventricular Arrhythmias An 8-year Experience
GEHA A, ELEFTERIADES J, HSU J, BIBLO L, HOCH D, BATSFORD W, ROSENFELD L, CARLSON M, JOHNSON N, WALDO A. Strategies in the Surgical Treatment of Malignant Ventricular Arrhythmias An 8-year Experience. Annals Of Surgery 1992, 216: 309-317. PMID: 1417180, PMCID: PMC1242614, DOI: 10.1097/00000658-199209000-00010.Peer-Reviewed Original ResearchConceptsAutomatic implantable cardioverter defibrillatorSubendocardial resectionVentricular tachycardiaSurgical treatmentLV aneurysmSudden deathThirty-day mortality rateSevere LV dysfunctionCongestive heart failureRecurrent ventricular tachycardiaSignificant myocardial ischemiaLong-term survivorsMalignant ventricular arrhythmiasMalignant ventricular tachyarrhythmiasCent of survivorsImplantable cardioverter defibrillatorLong-term survivalActuarial survivalAntiarrhythmic medicationsLate deathsComparable patientsLV dysfunctionConsecutive patientsHeart failureVentricular arrhythmiasAntiarrhythmic drug exacerbation of ventricular tachycardia inducibility during electrophysiologic study
Sager P, Perlmutter R, Rosenfeld L, Batsford W. Antiarrhythmic drug exacerbation of ventricular tachycardia inducibility during electrophysiologic study. American Heart Journal 1992, 123: 926-933. PMID: 1550002, DOI: 10.1016/0002-8703(92)90698-u.Peer-Reviewed Original ResearchConceptsTest-negative groupInducible ventricular tachycardiaTest positive groupVentricular tachycardiaElectrophysiologic studyVentricular arrhythmiasClinical characteristicsSignificant organic heart diseaseInducible sustained ventricular tachycardiaDrug-induced exacerbationGroups' clinical characteristicsInducible ventricular arrhythmiasDrug testsVentricular ejection fractionVentricular tachycardia inductionOrganic heart diseaseSustained ventricular tachycardiaBundle branch blockDrug-free stateVentricular tachycardia inducibilityTachycardia inductionAntiarrhythmic therapyInducible arrhythmiasEjection fractionVentricular aneurysm
1990
Evolving patterns in the surgical treatment of malignant ventricular tachyarrhythmias
Elefteriades J, Biblo L, Batsford W, Rosenfeld L, Henthorn R, Carlson M, Waldo A, Hsu J, Geha A. Evolving patterns in the surgical treatment of malignant ventricular tachyarrhythmias. The Annals Of Thoracic Surgery 1990, 49: 94-100. PMID: 2297279, DOI: 10.1016/0003-4975(90)90362-a.Peer-Reviewed Original ResearchConceptsAutomatic implantable cardioverter defibrillatorResection groupThirty-day mortalityCoronary artery bypassMalignant ventricular tachyarrhythmiasIntractable ventricular arrhythmiasImplantable cardioverter defibrillatorAICD placementArtery bypassSurgical treatmentEndocardial resectionVentricular arrhythmiasVentricular tachyarrhythmiasAntiarrhythmic agentsSudden deathCardioverter defibrillatorResectionMortality figuresPatientsEffective interventionsGreatest overall benefitSurvivalGroupOverall benefitValuable alternative
1989
Predictors of rhythm disturbances and subsequent morbidity after the Fontan operation
Weber H, Hellenbrand W, Kleinman C, Perlmutter R, Rosenfeld L. Predictors of rhythm disturbances and subsequent morbidity after the Fontan operation. The American Journal Of Cardiology 1989, 64: 762-767. PMID: 2801527, DOI: 10.1016/0002-9149(89)90761-3.Peer-Reviewed Original ResearchConceptsLate postoperative arrhythmiasPostoperative arrhythmiasLong-term survivorsLate arrhythmiasFontan operationNew York Heart Association functional class IGreater P-wave durationPredictors of arrhythmiasSupraventricular ectopic activityTachy-brady syndromeProportion of patientsFunctional class IP-wave durationSubsequent morbidityAtrial tachyarrhythmiasPreoperative electrocardiogramSinus rhythmSurgical dataRhythm disturbancesEctopic activityP wave deflectionLead V1PatientsArrhythmiasClass I
1988
Electrophysiologic effects of thrombolytic therapy in patients with a transmural anterior myocardial infarction complicated by left ventricular aneurysm formation
Sager P, Perlmutter R, Rosenfeld L, McPherson C, Wackers F, Batsford W. Electrophysiologic effects of thrombolytic therapy in patients with a transmural anterior myocardial infarction complicated by left ventricular aneurysm formation. Journal Of The American College Of Cardiology 1988, 12: 19-24. PMID: 3379204, DOI: 10.1016/0735-1097(88)90350-6.Peer-Reviewed Original ResearchConceptsGroup B patientsLeft ventricular aneurysm formationTransmural anterior myocardial infarctionGroup A patientsVentricular aneurysm formationAnterior myocardial infarctionThrombolytic therapyB patientsVentricular tachycardiaA patientsVentricular arrhythmiasMyocardial infarctionAneurysm formationNew bundle branch blockPeak creatine kinase-MB levelsLeft ventricular ejection fractionCreatine kinase-MB levelsClinical arrhythmic eventsEarly thrombolytic therapyCongestive heart failureVentricular ejection fractionSustained ventricular tachycardiaInduced ventricular arrhythmiasBundle branch blockPostmyocardial infarction patients